Not So Different: a Podcast from The Center for Biosimilars
Not So Different: A Podcast from The Center for Biosimilars
"Not So Different," a podcast from The Center for Biosimilars, brings you expert viewpoints from physicians, pharmacists, patients, developers, and other stakeholders in the complex world of biosimilar therapies.
Автор
Not So Different: a Podcast from The Center for Biosimilars
Категорія
Сайт подкасту
Останній епізод
30 лис 2025
Де слухати?
Подкасти в застосунку Replaio Radio Уже незабаромПодкасти незабаром з'являться в застосунку. Встановіть уже зараз і першими побачте зовсім новий погляд на подкасти
Встановіть безкоштовно
Android майже 10 млн завантажень · рейтинг 4,8
iOS незабаром
Епізоди
S4 Ep9: Dr Juliette Petit: How Nurses Prevent Nocebo Effect in Biosimilar Switching 28.03.2021 11:50
Learn more about Dr Petit’s study .
S4 Ep8: Minnesota Legislator Discusses Bill to Broaden Biosimilar Coverage 14.03.2021 10:52
To learn more about the bill, click here . To read the bill’s official text, click here . To learn more about payer formulary preferences, click here .
S4 Ep7: Goodwin Attorneys Discuss Updates to Biosimilars Litigation Guide 07.03.2021 11:11
To learn more about Valenti and Cerwicki's updated guide, click here . To learn more about adalimumab patent disputes, click here . To learn more about the future state for the adalimumab market, click here . To take our quiz on adalimumab, click here .
S4 Ep6: Anar Dossa Discusses Success and Savings With British Columbia’s Biosimilars Initiative 28.02.2021 12:23
To learn more about phase 3 of the BC Biosimilars Initiative, click here . To learn more about recent biosimilar launches in Canada, click here or here . To learn more about biosimilar switches in Canada, click here . To learn more about other Canadian province’s biosimilar plans, click here . To learn more about Pacific Blue Cross’s success with the program, click here .
S4 Ep5: Sarfaraz Niazi, PhD Discusses Market Projections For High-Concentration Adalimumab Biosimilars 21.02.2021 13:20
To learn more about Celltrion's EU approval, click here . To learn more about Alvotech’s high concentration adalimumab, click here . To learn more about high-concentration citrate-free adalimumab products, click here . To learn about the patent dance, click here . For more in adalimumab news, click here or here .
S4 Ep4: Steven Lucio Discusses BI’s Citizen Petition and the Current Status of Biosimilars 14.02.2021 12:45
To learn more about BI’s citizen petition, click here . To hear more from Steven Lucio, PharmD, BCPS, click here . To learn more about Vizient, click here .
S4 Ep3: The Race to the Top: Does China Have What it Takes? 07.02.2021 5:00
You can read more about China’s market by clicking here or here . For information on Bio-Thera, click here . For information on Shanghai Henlius Biotech, click here .
S4 Ep2: Why You Should Keep Your Eye on Ophthalmology Biosimilars 24.01.2021 7:57
To read more on Dr Oskouei's contributor piece, click here .
S4 Ep1: Charles Bennett, MD, PhD, Discusses Why the FTC Needs to Join the Effort to Improve the Biosimilar Market 10.01.2021 9:29
To read more about Bennett's study, click here .
S3 Ep32: Sean McGowan on What’s in Store for Biosimilars in 2021 and Beyond 06.12.2020 10:41
To watch the full first part of this interview, click here . To watch part 2 of this interview, click here . To watch part 3 of this interview, click here .
S3 Ep31: A Trio of Experts’ Take on What Needs to Change to Boost Biosimilar Adoption 29.11.2020 8:57
To learn more about biosimilar barriers, click here . To learn more about the US Oncology Network, click here . To learn more about McKesson, click here .
S3 Ep30: Kathy Oubre On What Practices Can Learn About the Benefits of Implementing Biosimilars 15.11.2020 9:09
To learn more about the COA's virtual Payer Exchange Summit on Oncology Payment Reform, click here . To learn more about Pontchartrain Cancer Center, click here .
S3 Ep29: Steven C. Hill, PhD, Discusses Rebates and Specialty Drug Spending 08.11.2020 12:26
To learn more about this study, click here .
S3 Ep28: Nancy Globus, PharmD, on Whether Comparative Efficacy Trials are Necessary 25.10.2020 7:46
To learn more about the study mentioned in this podcast, click here . To learn more about the United Kingdom's stance on comparative efficacy trials, click here .
S3 Ep27: Kathy Oubre on What Oncology Practices Lacked During the Pandemic 18.10.2020 14:17
To learn more about COVID-19’s impact on biosimilars, check out our ebook here .
S3 Ep26: Kanika Monga, MD, and Angus Worthing, MD, Discuss ACR Survey on Biosimilars and COVID-19 11.10.2020 12:09
To learn more about the ACR’s survey, click here . To learn more about COVID-19’s impact on biosimilars, check out our ebook here .
S3 Ep25: Wayne Winegarden, PhD, On Why Importing Drugs From Canada Is a Bad Idea 04.10.2020 8:59
To read more on Wayne’s thoughts of this plan, click here . To learn more about the Safe Importation Action Plan, click here . To learn more about President Trump’s executive orders, click here .
S3 Ep24: Julie Kennerly-Shah, PharmD, on How Biosimilars Can Help Curb COVID-19's Impact 27.09.2020 10:55
To learn more about COVID-19's impact on biosimilars, click here . To learn more about biosimilar education, click here . To learn more about step therapy, click here . To learn more about payer interference on preferred drugs, click here .
S3 Ep23: Rep Grothman on His Bill to Make Biosimilar Insulins Interchangeable 20.09.2020 9:03
To learn more about HR 8190, click here . To learn more about the regulatory transition of insulin under the BPCIA, click here . To learn more about interchangeability designations, click here .
S3 Ep22: Alex Moulson on How Companies Choose Which Biosimilars to Produce 13.09.2020 9:54
To check out more of our coverage of Polpharma Biologics, click here . To learn more about Polpharma's natalizumab clinical trial, click here . To learn about Polpharma Biologics recent integration efforts, click here . To learn more about Polpharma Biologics, click here .
S3 Ep21: Cheryl Larson on How Employers Can Get Biosimilars Added to Their Health Plan 06.09.2020 10:37
To learn more about MBGH's call to action for employers, click here . To learn more about MBGH's biosimilars report, click here . To learn more about Midwest Business Group on Health, click here .
S3 Ep20: Jonathan Sweeting on Aybintio's European Approval 30.08.2020 9:14
To learn more about the EC's approval of Aybintio, click here . To learn more about Samsung Bioepis, click here .
S3 Ep19: Nancy Globus, PharmD, on the Effect of Biosimilar Suffixes 23.08.2020 6:14
To learn more about biosimilar naming, click here . Click here to learn more about the ACMA.
S3 Ep18: Carter Thorne, MD, Discusses Biosimilar Switching in Canada 16.08.2020 7:54
To learn more about Canadian switching policies, click here .
S3 Ep17: Sizing Up European Biosimilar Competition 09.08.2020 9:32
To check out the scorecard, click here . To learn more about Medicines for Europe, click here .
Схожі подкасти
Слухайте подкаст Not So Different: A Podcast from The Center for Biosimilars у Replaio
Радіо та подкасти в одному застосунку - безкоштовно й без реєстрації. Встановіть уже сьогодні та не пропустіть запуск
Replaio не є видавцем подкастів; назви шоу, обкладинки та аудіо належать їхнім авторам і поширюються через публічні RSS-канали
